Business Wire

Quidel Opens New Manufacturing Facility to Mass Produce QuickVue® Rapid Antigen Tests for COVID-19

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Nasdaq

QuidelOrtho's (QDEL) QuickVue Gets FDA Nod for COVID Testing

QuidelOrtho Corporation QDEL recently announced the FDA 510(k) clearance for its QuickVue COVID-19 test.With CLIA certificates of waiver, this approval permits the test to be used accurately and ...
Business Wire

QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test

SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho" or the “Company”) has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its QuickVue COVID-19 ...
Salon

Did your at-home COVID test yield a false negative? You’re not alone — here’s what’s going on

As COVID-19 case numbers have been slowly rising across the United States, Americans are turning to at-home rapid antigen tests to suss out whether they are sick from a good-old fashioned cold, the ...
AOL

How to shop for at-home Covid tests, according to medical experts

Select independently determines what we cover and recommend. When you buy through our links, we may earn a commission. Learn more. Gone are the days of visiting a doctor’s office to determine whether ...
Nasdaq

QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test

Designed for symptomatic individuals within six days of symptom onset, the QuickVue COVID-19 test is cleared for use in individuals aged 14 or older when self-testing, and in those aged two and older ...